Cleared Traditional

INFLUENZA B ANITGEN TEST

K942174 · Neogenex · Microbiology
Jun 1994
Decision
56d
Days
Class 1
Risk

About This 510(k) Submission

K942174 is an FDA 510(k) clearance for the INFLUENZA B ANITGEN TEST, a Antisera, Cf, Influenza Virus A, B, C (Class I — General Controls, product code GNW), submitted by Neogenex (Everett, US). The FDA issued a Cleared decision on June 30, 1994, 56 days after receiving the submission on May 5, 1994. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3330.

Submission Details

510(k) Number K942174 FDA.gov
FDA Decision Cleared SESE
Date Received May 05, 1994
Decision Date June 30, 1994
Days to Decision 56 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code GNW — Antisera, Cf, Influenza Virus A, B, C
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3330

Similar Devices — GNW Antisera, Cf, Influenza Virus A, B, C

All 15
D3 FASTPOINT L-DFA INFLUENZA A/INFLUENZA B VIRUS IDENTIFICATION KIT
K092882 · Diagnostic Hybrids, Inc. · Oct 2009
MODIFICATION TO D3 ULTRA DFA RESPIRATORY VIRUS SCREENING & ID KIT
K092300 · Diagnostic Hybrids, Inc. · Aug 2009
D3 DUET DFA INFLUENZA A/RESPIRATORY VIRUS SCREENING KIT
K081746 · Diagnostic Hybrids, Inc. · Dec 2008
D3 ULTRA DFA RESPIRATORY VIRUS SCREENING & ID KIT
K061101 · Diagnostic Hybrids, Inc. · Nov 2006
DFA RESPIRATORY VIRUS SCREENING & ID KIT
K022713 · Diagnostic Hybrids, Inc. · Dec 2002
BARTELS VIRAL RESPIRATORY SCREENING AND IDENTIFICATION KIT
K003204 · Intracel Corp. · Nov 2000